Dr. Michael Byrne is a hematologist at Tennessee Oncology Center for Blood Cancers.  He is the principal investigator of several clinical studies, oversees the Tennessee Oncology CHIP Clinic, is course director of the malignant hematology tumor board, and has led the launch the cellular therapy program.  Additionally, Michael is the Medical Director of Hematologic Malignancies at Ascension St Thomas Midtown.